Qlucore AB (publ) reported earnings results for the second quarter and six months ended October 31, 2024. For the second quarter, the company reported sales was SEK 4.88 million compared to SEK 9.85 million a year ago. Revenue was SEK 7.02 million compared to SEK 10.41 million a year ago. Net loss was SEK 5.95 million compared to SEK 3.26 million a year ago. Basic loss per share from continuing operations was SEK 1.48 compared to SEK 0.81 a year ago. Diluted loss per share from continuing operations was SEK 1.48 compared to SEK 0.81 a year ago. For the six months, sales was SEK 8.87 million compared to SEK 19.58 million a year ago. Revenue was SEK 12.08 million compared to SEK 21.25 million a year ago. Net loss was SEK 13.48 million compared to SEK 8.26 million a year ago. Basic loss per share from continuing operations was SEK 3.35 compared to SEK 2.05 a year ago. Diluted loss per share from continuing operations was SEK 3.35 compared to SEK 2.05 a year ago.
Qlucore is a Sweden-based bioinformatics software development company that provides solutions such as companion and clinical diagnostics for the biotechnology sector.